- 著者
- Hiroki Saito Takanori Funaki Kazuhiro Kamata Kazuhiko Ide Sachiko Nakamura Yasunori Ichimura Kazuaki Jindai Takeshi Nishijima Rieko Takahashi McLellan Chiori Kodama Jun Sugihara Shinya Tsuzuki Mugen Ujiie Hiroyuki Noda Kazunari Asanuma
- 出版者
- National Center for Global Health and Medicine
- 雑誌
- Global Health & Medicine (ISSN:24349186)
- 巻号頁・発行日
- pp.2019.01032, (Released:2020-01-27)
- 参考文献数
- 11
- 被引用文献数
- 1
In 2015, Japan created a unique governmental program to train experts in health emergencies called Infectious Disease Emergency Specialist (IDES). This is a concept paper to set out the goal and structure of the program, and to describe the achievement and the way forward to further contribute to global health security. The IDES program background, mission, structure, achievement, and future directions were reviewed and discussed by the IDES trainees, graduates, and program coordinators/supervisors. Since 2015, thirteen Japanese medical doctors have graduated from the program while five are currently in training. The IDES core competencies were identified in the context of a wide range of skillsets required for health emergencies. A large national and global network has been created through the training. Coordinated work with surge capacity of experts is of paramount importance to prepare for and respond to public health emergencies. The IDES program can be a good model to many other governments, and contribute to global health security.
- 著者
- Mami Wakabayashi Yasunori Ichimura Eiichi Shimizu Tomoko Nishioka Yuzuru Kono Masahiko Doi Yuriko Egami Tomoka Kadowaki Hiroyasu Iso Noriko Fujita
- 出版者
- National Center for Global Health and Medicine
- 雑誌
- GHM Open (ISSN:2436293X)
- 巻号頁・発行日
- pp.2021.01032, (Released:2022-02-26)
- 参考文献数
- 20
- 被引用文献数
- 1
The World Health Organization (WHO) has been utilizing Emergency Use Listing (EUL) to expand access to medical products during the COVID-19 pandemic. EUL is a risk-based procedure for assessing and listing unlicensed vaccines, medicine, and in vitro diagnostics. To determine whether Japanese medical products acquired EUL relating to COVID-19, we conducted desk research as a part of a new project. Results showed that thirteen of twenty-eight in vitro diagnostic products were from China and three of ten vaccines on EUL were from India. However, only one vaccine manufactured in Japan was on EUL. A common weakness of Japanese companies in the global public procurement market was a lack of knowledge on qualification systems for medical products. We hypothesized holistic approaches from private companies and systematic supports from public sectors are required for a response to an emergency. These activities could lead to contribute to global health issues through sustainable businesses.